$INO began human testing in April, expects to report results of trial later in June. No cure yet but DoD gives $71 mln to scale production. 

Up 40% from Tuesday, expecting to see results to support it's bullish trend. 

#stocks #covidvaccine #Inovio #stockstowatch #bullish https://t.co/UJ8z64Us9M